North America Non-Small Cell Lung Cancer Diagnostics Market – Industry Trends and Forecast to 2028

Customize Your Report Customize Your Report Buy Now Buy Now Free Sample Report Free Sample Report
back-icon

Back to Report
Home Medical Devices North America Non Small Cell Lung Cancer Diagnostics Market Table of Content
Request for TOC Request for TOC Speak to Analyst Speak to Analyst Free Sample Report Free Sample Report Inquire Before Buying Inquire Before Buy Now Buy Now

North America Non-Small Cell Lung Cancer Diagnostics Market – Industry Trends and Forecast to 2028

  • Medical Devices
  • Published Report
  • Sep 2021
  • North America
  • 350 Pages
  • No of Tables: 37
  • No of Figures: 21
Buy Now Buy Now Request for Sample Request for Sample
Nucleus Nucleus

Table of Content

  1. introduction
    1. OBJECTIVES OF THE STUDY
    2. MARKET DEFINITION
    3. OVERVIEW OF NORTH AMERICA NON-SMALL CELL LUNG CANCER DIAGNOSTICS MARKET
    4. LIMITATIONS
    5. MARKETS COVERED
  2. MARKET SEGMENTATION
    1. MARKETS COVERED
    2. geographical scope
    3. years considered for the study
    4. Currency and pricing
    5. DBMR TRIPOD DATA VALIDATION MODEL
    6. MULTIVARIATE MODELLING
    7. cancer type LIFELINE CURVE
    8. DBMR MARKET POSITION GRID
    9. vendor share analysis
    10. secondary sourcEs
    11. assumptions
  3. EXECUTIVE SUMMARY
  4. PREMIUM INSIGHTS
    1. ROLE OF ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING
    2. Product and Brand Analysis: North America Non-Small Cell Lung Cancer Diagnostics Market
    3. Abbott Laboratories-
    4. F. Hoffmann-La Roche Ltd -
    5. Agilent Technologies, Inc.
    6. QIAGEN
    7. Thermo Fisher Scientific, Inc
    8. Quest Diagnostics Incorporated
    9. NeoGenomics Laboratories, Inc.
    10. NanoString
    11. Janssen Pharmaceutical NV
    12. Inivata Ltd
    13. bioMérieux SA
    14. Biotheranostics, Inc.
    15. Oncocyte Corporation
    16. Eckert & Ziegler
    17. General Electric Company
    18. Dr Lal PathLabs
    19. Riverain Technologies
    20. PlexBio Co.,Ltd
    21. Biodesix
    22. Oncimmune
  5. market overview
    1. Drivers
      1. RISE IN prevalence of LUNG cancer Across the world
      2. Growing number of geriatric population that is more susceptible to non-small cell lung cancer
      3. Growing collaboration partnership and agreement by the key players
      4. Growing usage of artificial intelligence and machine learning to improve the diagnostic procedures
      5. Increasing prevalence of unhealthy lifestyle that poses a serious risk of lung cancer
      6. GROWING PRODUCT LAUNCHES
    2. restraintS
      1. CHALLENGES ASSOCIATED WITH BRAND EQUITY
      2. Maintaining high level of expertise for diagnosis purpose
    3. OPPORTUNITIES
      1. rising healthcare expenditure in developing region
      2. increasing adoption of new technology to diagnose non-small cell lung cancer
      3. increase in the number of approvals for non-small cell lung cancer products
    4. Challenges
      1. high competition among market players
      2. disturbed supply chain due to COVID-19
  6. IMPACT OF COVID-19 ON THE NORTH AMERICA NON SMALL CELL LUNG CANCER DIAGNOSTIC MARKET
    1. IMPACT ON DEMAND
    2. IMPACT ON SUPPLY CHAIN
    3. IMPACT ON PRICE
    4. CONCLUSION
  7. North America non-small cell lung cancer diagnostics Market, by lung Cancer type
    1. OVERVIEW
    2. Lung Adenocarcinoma (LUAD)
    3. Lung Squamous Cell Carcinoma (LUSC)
    4. Large Cell Carcinoma
    5. OTHERS
  8. North America non-small cell lung cancer diagnostics Market, by Product
    1. overview
    2. Instruments
    3. Reagents and Kits
      1. Lung Cancer Assay Kit
      2. Mutation Kit
      3. Extraction Kit
      4. Sample Preparation Kit
      5. Solid Tumour Kit
      6. Others
    4. Services and Softwares
  9. North America non-small cell lung cancer diagnostics Market, by Test
    1. OVERVIEW
    2. Molecular Test
      1. RT-PCR
      2. Next-GENERATION Sequencing (NGS)
      3. DNA Microarray
      4. Next Generation Capture
      5. Lab-On -A Chip (LOAC)
      6. Multiplex Conventional
      7. Protein Microarray
      8. Other
    3. Imaging Test
      1. Pisitron Emission Tomography (PET) Scan
      2. Magnetic Resonance imaging (MRI) scan
      3. CT Scan
      4. Bone Scan
      5. Others
    4. Immunohistochemistry
    5. Biopsy
    6. Sputum Cytology
    7. Thorecentesis
    8. Others
  10. North America non-small cell lung cancer diagnostics Market, by End user
    1. OVERVIEW
    2. Clinical Laboratories
    3. Hospital
    4. Academics
    5. Institutes and Research Centers
  11. North America Non-Small Cell Lung Cancer Diagnostics Market by country
    1. North america
      1. U.S.
      2. canada
      3. mexico
  12. North America Non-Small Cell Lung Cancer Diagnostics Market: COMPANY landscape
    1. company share analysis: North america
  13. Swot analysis
  14. Company profile
    1. ABBOTT LABORATORIES
      1. COMPANY SNAPSHOT
      2. revenue analysis
      3. COMPANY SHARE ANALYSIS
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENT
    2. f. hoffmann-la roche ltd
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. COMPANY SHARE ANALYSIS
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    3. quest diagnostics incorporated
      1. COMPANY SNAPSHOT
      2. revenue analysis
      3. COMPANY SHARE ANALYSIS
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENT
    4. general electric company
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. COMPANY SHARE ANALYSIS
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    5. nanoString
      1. COMPANY SNAPSHOT
      2. revenue analysis
      3. COMPANY SHARE ANALYSIS
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENT
    6. agilent technologies, inc.
      1. COMPANY SNAPSHOT
      2. revenue analysis
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    7. Biodesix
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    8. biomerieux sa
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    9. biotheranostics
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    10. Dr Lal PathLabs
      1. COMPANY SNAPSHOT
      2. revenue analysis
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    11. Eckert & Ziegler
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    12. inivata ltd
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    13. janssen pharmaceutical nv
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    14. neogenomics laboratories, inc.
      1. COMPANY SNAPSHOT
      2. revenue analysis
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    15. oncimmune
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    16. OncoCyte Corporation
      1. COMPANY SNAPSHOT
      2. product portfolio
      3. RECENT DEVELOPMENTS
    17. PLExibio co ltd
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. product portfolio
      4. RECENT DEVELOPMENT
    18. qiagen
      1. COMPANY SNAPSHOT
      2. revenue analysis
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    19. RIVERAIN TECHNOLOGIES
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    20. thermo Fisher scientific inc.
      1. COMPANY SNAPSHOT
      2. revenue analysis
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
  15. questionnaire
  16. related reports

List of Table

TABLE 1 AGING WORLD POPULATION

TABLE 2 North America non-small cell lung cancer diagnostics Market, By lung Cancer type, 2019-2028 (usd million)

TABLE 3 North America non-small cell lung cancer diagnostics Market, By Product, 2019-2028 (USD million)

TABLE 4 North America Reagents and Kits In Non-Small Cell Lung Cancer Diagnostics Market, By Product, 2019-2028 (USD million)

TABLE 5 North America non-small cell lung cancer diagnostics Market, By Test, 2019-2028 (USD million)

TABLE 6 North America MOLECULAR TEST IN NON-SMALL CELL LUNG CANCER DIAGNOSTICS MARKET, By Test, 2019-2028 (USD million)

TABLE 7 North America Imaging Test In Non-Small Cell Lung Cancer Diagnostics Market, By Test, 2019-2028 (USD million)

TABLE 8 North America non-small cell lung cancer diagnostics Market, By End user, 2019-2028 (USD million)

TABLE 9 North America Non-Small Cell Lung Cancer Diagnostics Market, By Country, 2019-2028 (USD Million)

TABLE 10 North America Non-Small Cell Lung Cancer Diagnostics Market, By LUNG CANCER TYPE, 2019-2028 (USD MILLION)

TABLE 11 North America Non-Small Cell Lung Cancer Diagnostics Market, By Product, 2019-2028 (USD Million)

TABLE 12 North America Reagents and Kits IN Non-Small Cell Lung Cancer Diagnostics Market, By Product, 2019-2028 (USD Million)

TABLE 13 North America Non-Small Cell Lung Cancer Diagnostics Market, By Test, 2019-2028 (USD Million)

TABLE 14 North America imaging test in Non-Small Cell Lung Cancer Diagnostics Market, By test, 2019-2028 (USD Million)

TABLE 15 North America molecular test in Non-Small Cell Lung Cancer Diagnostics Market, By test, 2019-2028 (USD Million)

TABLE 16 North America Non-Small Cell Lung Cancer Diagnostics Market, By End User, 2019-2028 (USD Million)

TABLE 17 U.S. Non-Small Cell Lung Cancer Diagnostics Market, By LUNG CANCER TYPE, 2019-2028 (USD MILLION)

TABLE 18 U.S. Non-Small Cell Lung Cancer Diagnostics Market, By Product, 2019-2028 (USD Million)

TABLE 19 U.S. Non-Small Reagents and Kits IN Cell Lung Cancer Diagnostics Market, By Product, 2019-2028 (USD Million)

TABLE 20 U.S. Non-Small Cell Lung Cancer Diagnostics Market, By Test, 2019-2028 (USD Million)

TABLE 21 U.S. imaging test in Non-Small Cell Lung Cancer Diagnostics Market, By test, 2019-2028 (USD Million)

TABLE 22 U.S. molecular test in Non-Small Cell Lung Cancer Diagnostics Market, By test, 2019-2028 (USD Million)

TABLE 23 U.S. Non-Small Cell Lung Cancer Diagnostics Market, By End User, 2019-2028 (USD Million)

TABLE 24 CANADA Non-Small Cell Lung Cancer Diagnostics Market, By LUNG CANCER TYPE, 2019-2028 (USD MILLION)

TABLE 25 CANADA Non-Small Cell Lung Cancer Diagnostics Market, By Product, 2019-2028 (USD Million)

TABLE 26 CANADA Reagents and Kits IN Non-Small Cell Lung Cancer Diagnostics Market, By Product, 2019-2028 (USD Million)

TABLE 27 CANADA Non-Small Cell Lung Cancer Diagnostics Market, By Test, 2019-2028 (USD Million)

TABLE 28 CANADA imaging test in Non-Small Cell Lung Cancer Diagnostics Market, By test, 2019-2028 (USD Million)

TABLE 29 CANADA molecular test in Non-Small Cell Lung Cancer Diagnostics Market, By test, 2019-2028 (USD Million)

TABLE 30 CANADA Non-Small Cell Lung Cancer Diagnostics Market, By End user, 2019-2028 (USD Million)

TABLE 31 MEXICO Non-Small Cell Lung Cancer Diagnostics Market, By LUNG CANCER TYPE, 2019-2028 (USD MILLION)

TABLE 32 MEXICO Non-Small Cell Lung Cancer Diagnostics Market, By Product, 2019-2028 (USD Million)

TABLE 33 MEXICO Reagents and Kits IN Non-Small Cell Lung Cancer Diagnostics Market, By Product, 2019-2028 (USD Million)

TABLE 34 MEXICO Non-Small Cell Lung Cancer Diagnostics Market, By Test, 2019-2028 (USD Million)

TABLE 35 MEXICO imaging test in Non-Small Cell Lung Cancer Diagnostics Market, By test, 2019-2028 (USD Million)

TABLE 36 MEXICO molecular test in Non-Small Cell Lung Cancer Diagnostics Market, By test, 2019-2028 (USD Million)

TABLE 37 MEXICO Non-Small Cell Lung Cancer Diagnostics Market, By End User, 2019-2028 (USD Million)

List of Figure

FIGURE 1 NORTH AMERICA NON-SMALL CELL LUNG CANCER DIAGNOSTICS MARKET: segmentation

FIGURE 2 North America non-small cell lung cancer diagnostics market: data triangulation

FIGURE 3 NORTH AMERICA NON-SMALL CELL LUNG CANCER DIAGNOSTICS MARKET: DROC ANALYSIS

FIGURE 4 North America non-small cell lung cancer diagnostics market: NORTH AMERICA vs REGIONAL MARKET ANALYSIS

FIGURE 5 NORTH AMERICA NON-SMALL CELL LUNG CANCER DIAGNOSTICS MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 NORTH AMERICA NON-SMALL CELL LUNG CANCER DIAGNOSTICS MARKET: DBMR MARKET POSITION GRID

FIGURE 7 NORTH AMERICA NON-SMALL CELL LUNG CANCER DIAGNOSTICS MARKET: DBMR VENDOR SHARE ANALYSIS

FIGURE 8 NORTH AMERICA NON-SMALL CELL LUNG CANCER DIAGNOSTICS MARKET: SEGMENTATION

FIGURE 9 RISE IN THE geriatric population that is more susceptible to non-small cell lung cancer is expected to drive the North America non-small cell lung cancer diagnostics market in THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 10 Lung adenocarcinoma (LUAD) SEgment is expected to account for the largest share of the NORTH AMERICA NON-SMALL CELL LUNG CANCER DIAGNOSTICS MARKET in 2021 & 2028

FIGURE 11 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF NORTH AMERICA NON-SMALL CELL LUNG CANCER DIAGNOSTICS MARKET

FIGURE 12 North America non-small cell lung cancer diagnostics Market, By lung Cancer type, 2020

FIGURE 13 North America non-small cell lung cancer diagnostics Market, By Product, 2020

FIGURE 14 North America non-small cell lung cancer diagnostics Market, By Test, 2020

FIGURE 15 North America non-small cell lung cancer diagnostics Market, By End user, 2020

FIGURE 16 North America non-small cell lung cancer diagnostics market: SNAPSHOT (2020)

FIGURE 17 North America non-small cell lung cancer diagnostics market: BY COUNTRY (2020)

FIGURE 18 North America non-small cell lung cancer diagnostics market: BY COUNTRY (2021 & 2028)

FIGURE 19 North America non-small cell lung cancer diagnostics market: BY COUNTRY (2020 & 2028)

FIGURE 20 North America non-small cell lung cancer diagnostics market: BY lung cancer TYPE (2021 & 2028)

FIGURE 21 North america Non-Small Cell Lung Cancer Diagnostics Market: company share 2020 (%)

Browse Related Pages

Banner